Actinium Pharmaceuticals Inc (ATNM) — Cash Flow-to-Debt Ratio
Actinium Pharmaceuticals Inc (ATNM) has a Cash Flow-to-Debt Ratio of -0.14x as of March 2026, meaning its operating cash flow of $-5.87 Million could theoretically repay 0% of its total liabilities ($43.13 Million) in one year. See Actinium Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Actinium Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Actinium Pharmaceuticals Inc across 20 annual periods. Also explore Actinium Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Actinium Pharmaceuticals Inc (2006–2025)
Year-by-year debt coverage analysis for Actinium Pharmaceuticals Inc. For market capitalisation and broader financial context, see ATNM market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.56x | $-24.58 Million | $43.94 Million | ▲ +25.3% |
| 2024 | -0.75x | $-33.07 Million | $44.14 Million | ▲ +28.7% |
| 2023 | -1.05x | $-47.34 Million | $45.07 Million | ▼ -679.7% |
| 2022 | 0.18x | $8.64 Million | $47.71 Million | ▲ +105.9% |
| 2021 | -3.05x | $-20.87 Million | $6.84 Million | ▲ +28.4% |
| 2020 | -4.26x | $-21.62 Million | $5.08 Million | ▼ -19.5% |
| 2019 | -3.56x | $-21.46 Million | $6.03 Million | ▼ -5.2% |
| 2018 | -3.39x | $-20.57 Million | $6.08 Million | ▲ +26.7% |
| 2017 | -4.62x | $-21.55 Million | $4.67 Million | ▼ -0.4% |
| 2016 | -4.60x | $-20.79 Million | $4.52 Million | ▼ -14.4% |
| 2015 | -4.02x | $-18.54 Million | $4.61 Million | ▼ -165.9% |
| 2014 | -1.51x | $-14.35 Million | $9.49 Million | ▼ -76.0% |
| 2013 | -0.86x | $-6.29 Million | $7.33 Million | ▲ +23.5% |
| 2012 | -1.12x | $-5.21 Million | $4.64 Million | ▼ -17695.7% |
| 2011 | 0.01x | $539.00 | $84.48K | ▼ -92.3% |
| 2010 | 0.08x | $7.83K | $94.77K | ▲ +143.3% |
| 2009 | -0.19x | $-18.78K | $98.41K | ▼ -4.1% |
| 2008 | -0.18x | $-13.96K | $76.18K | ▲ +53.1% |
| 2007 | -0.39x | $-15.49K | $39.64K | ▲ +47.4% |
| 2006 | -0.74x | $-14.03K | $18.87K | — |